Advertise on podcast: Hematology / Oncology @Point of Care Podcasts

Explore the evolving role of oral SERDs in HR-positive, HER2-negative advanced breast cancer. Hear expert perspectives on ESR1 mutation testing, treatment selection and sequencing, emerging combination strategies, circulating tumor DNA (ctDNA) monitoring, and safety considerations that may inform individualized treatment decisions. Visit https://suitehome.atpointofcare.com/library/2760.12/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

Stay ahead of evolving endocrine resistance in HR-positive, HER2-negative advanced breast cancer. Discover how ESR1 mutations are reshaping treatment decisions, and explore expert perspectives on mutation testing, oral SERDs, and emerging serial monitoring strategies that may help identify resistance earlier and inform individualized patient care. Visit https://suitehome.atpointofcare.com/library/2760.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

Advance your approach to locally recurrent or metastatic anal cancer with expert, case-based insights into retifanlimab-based therapy, special patient populations, toxicity management, and care after progression. Learn how patient-specific factors can shape therapeutic decisions throughout the disease course—tune in now for practical perspectives you can apply in clinical practice. Visit https://www.atpointofcare.com/library/2750.03/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

Tune in to this podcast to refine your approach to locally recurrent or metastatic squamous cell carcinoma of the anal canal. Review the evidence for first-line retifanlimab plus carboplatin and paclitaxel, and gain practical insights to individualize treatment, optimize maintenance therapy, monitor safety, and integrate chemoimmunotherapy into clinical practice. Visit https://www.atpointofcare.com/library/2750.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

Stay ahead in the evolving landscape of anal cancer care with this CME activity. Recognize patients at higher risk for squamous cell carcinoma of the anus (SCAC). Start the education and screening process with clarity, confidence, and compassion. Discover the latest expert recommendations on SCAC risk factors, diagnostic and referral steps, and effective patient communication. Visit https://www.atpointofcare.com/library/2750.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

RAS-targeted therapies are reshaping the treatment landscape for pancreatic ductal adenocarcinoma, creating new challenges in understanding the mechanisms and potential clinical applications of allele-specific, pan-KRAS, and pan-RAS inhibitors. Join Dr. Eileen O’Reilly and Dr. Margaret Tempero as they explore the evolving RAS therapeutic pipeline and discuss how these emerging strategies may inform future treatment decisions. Visit https://suitehome.atpointofcare.com/library/2746.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

As biomarker-directed therapies expand in pancreatic ductal adenocarcinoma, comprehensive genomic profiling is becoming increasingly important for identifying actionable alterations and informing treatment decisions. Join Dr. Eileen O’Reilly and Dr. Margaret Tempero as they discuss when and how to perform genomic profiling, interpret key findings, and address practical challenges to obtaining clinically useful molecular information. Visit https://suitehome.atpointofcare.com/library/2746.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

This final episode of a three-part expert-led podcast series explores the emerging toxicity landscape as immunotherapy- and antibody-drug conjugate–based regimens enter the treatment of muscle-invasive bladder cancer. Faculty will discuss the mechanistic basis for these side effects, practical monitoring and management strategies, and the multidisciplinary coordination needed among oncology, urology, and subspecialists to navigate them safely. Visit https://suitehome.atpointofcare.com/library/2744.03/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

This expert-led podcast explores practical treatment selection in the evolving perioperative landscape for muscle-invasive bladder cancer. Faculty will discuss how to assess treatment eligibility, navigate immunotherapy-based and antibody-drug conjugate–based options, and coordinate care across specialties to support timely, individualized treatment decisions. Visit https://suitehome.atpointofcare.com/library/2744.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.

This expert-led podcast explores the rapidly evolving perioperative treatment landscape in muscle-invasive bladder cancer. Faculty will discuss pivotal data from NIAGARA, KEYNOTE-905, and KEYNOTE-B15, and consider how recent advances are expanding systemic treatment options, including for patients who are cisplatin-ineligible, and reshaping perioperative care. Visit https://suitehome.atpointofcare.com/library/2744.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. This podcast is powered by Pinecast.